RXRX

Recursion Pharmaceuticals, Inc.

• Simply Wall St·11h ago

  A Look At Recursion Pharmaceuticals (RXRX) Valuation As Investor Narratives Diverge On Future Potential

• Simply Wall St·1d ago

  Why Recursion (RXRX) Is Up 10.8% After Deepening Citeline Partnership To Power AI-Driven Clinical Trials

• Reuters·2d ago

  Recursion Pharmaceuticals director Christopher Gibson disposes 40,000 shares for $124,000

• Reuters·2d ago

  Recursion director Blake Borgeson disposes of 30,000 shares for $93,000

• TipRanks·3d ago

  Largest borrow rate increases among liquid names

• Simply Wall St·04/02 10:27

  Does AI Data Deal And New CMO Hire Change The Bull Case For Recursion (RXRX)?

• Simply Wall St·04/01 08:40

  A Look At Recursion Pharmaceuticals (RXRX) Valuation As Investor Narratives Diverge

• Benzinga·03/31 13:05

  Citeline Announces Expanded Strategic Partnership With Recursion, Advancing AI-Enabled ClinTech Platform

• Seeking Alpha·03/31 10:35

  Cathie Wood's Ark Invest in broad sell-off; trims AI, crypto, internet names

• TipRanks·03/25 21:07

  Recursion Pharmaceuticals Names New Chief Medical Officer

• Reuters·03/25 20:37

  Recursion Pharmaceuticals director Christopher Gibson drops 40,000 common shares; disposal totals $130,000

• Simply Wall St·03/25 17:11

  New Recursion CMO Puts Oncology Experience At Center Of Investor Focus

• Seeking Alpha·03/25 12:44

  Recursion names Vicki Goodman as CMO

• TipRanks·03/25 12:06

  Recursion Pharmaceuticals announces Vicki Goodman as chief medical officer

• Reuters·03/25 11:59

  Recursion names Vicki Goodman chief medical officer effective April 6, 2026; David Mauro exits after about three years